1. Home
  2. CPRX vs SXT Comparison

CPRX vs SXT Comparison

Compare CPRX & SXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • SXT
  • Stock Information
  • Founded
  • CPRX 2002
  • SXT 1882
  • Country
  • CPRX United States
  • SXT United States
  • Employees
  • CPRX N/A
  • SXT N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • SXT Major Chemicals
  • Sector
  • CPRX Health Care
  • SXT Industrials
  • Exchange
  • CPRX Nasdaq
  • SXT Nasdaq
  • Market Cap
  • CPRX 2.9B
  • SXT 2.9B
  • IPO Year
  • CPRX 2006
  • SXT N/A
  • Fundamental
  • Price
  • CPRX $23.37
  • SXT $95.65
  • Analyst Decision
  • CPRX Strong Buy
  • SXT Buy
  • Analyst Count
  • CPRX 7
  • SXT 1
  • Target Price
  • CPRX $32.29
  • SXT $93.00
  • AVG Volume (30 Days)
  • CPRX 975.9K
  • SXT 513.8K
  • Earning Date
  • CPRX 05-07-2025
  • SXT 04-25-2025
  • Dividend Yield
  • CPRX N/A
  • SXT 1.72%
  • EPS Growth
  • CPRX 178.13
  • SXT 41.11
  • EPS
  • CPRX 1.57
  • SXT 3.02
  • Revenue
  • CPRX $534,645,999.00
  • SXT $1,564,883,000.00
  • Revenue This Year
  • CPRX $15.59
  • SXT $3.84
  • Revenue Next Year
  • CPRX $8.90
  • SXT $4.39
  • P/E Ratio
  • CPRX $14.90
  • SXT $31.67
  • Revenue Growth
  • CPRX 29.97
  • SXT 6.30
  • 52 Week Low
  • CPRX $14.47
  • SXT $66.15
  • 52 Week High
  • CPRX $26.16
  • SXT $95.11
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 50.33
  • SXT 78.80
  • Support Level
  • CPRX $20.80
  • SXT $92.56
  • Resistance Level
  • CPRX $25.01
  • SXT $96.48
  • Average True Range (ATR)
  • CPRX 0.83
  • SXT 3.09
  • MACD
  • CPRX -0.06
  • SXT 0.73
  • Stochastic Oscillator
  • CPRX 61.05
  • SXT 96.09

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.

Share on Social Networks: